Bragagni M - Search Results

1

New series of sulfonamides containing amino acid moiety act as effective and selective inhibitors of tumor-associated carbonic anhydrase XII.

Ceruso M, Bragagni M, AlOthman Z, Osman SM, Supuran CT. Ceruso M, et al. Among authors: bragagni m. J Enzyme Inhib Med Chem. 2015 Jun;30(3):430-4. doi: 10.3109/14756366.2014.942659. Epub 2014 Aug 4. J Enzyme Inhib Med Chem. 2015. PMID: 25089707 Free article.

2

Cyclodextrin complexation highly enhances efficacy of arylsulfonylureido benzenesulfonamide carbonic anhydrase inhibitors as a topical antiglaucoma agents.

Bragagni M, Bozdag M, Carta F, Scozzafava A, Lanzi C, Masini E, Mura P, Supuran CT. Bragagni M, et al. Bioorg Med Chem. 2015 Sep 15;23(18):6223-7. doi: 10.1016/j.bmc.2015.07.047. Epub 2015 Jul 29. Bioorg Med Chem. 2015. PMID: 26319622

3

Synthesis of an acridine orange sulfonamide derivative with potent carbonic anhydrase IX inhibitory action.

Bragagni M, Carta F, Osman SM, AlOthman Z, Supuran CT. Bragagni M, et al. J Enzyme Inhib Med Chem. 2017 Dec;32(1):701-706. doi: 10.1080/14756366.2017.1302441. J Enzyme Inhib Med Chem. 2017. PMID: 28335646 Free PMC article.

4

Development and ex vivo evaluation of 5-aminolevulinic acid-loaded niosomal formulations for topical photodynamic therapy.

Bragagni M, Scozzafava A, Mastrolorenzo A, Supuran CT, Mura P. Bragagni M, et al. Int J Pharm. 2015 Oct 15;494(1):258-63. doi: 10.1016/j.ijpharm.2015.08.036. Epub 2015 Aug 14. Int J Pharm. 2015. PMID: 26283280

5

Selection of PLA polymers for the development of injectable prilocaine controlled release microparticles: usefulness of thermal analysis.

Bragagni M, Beneitez C, Martín C, Hernán Pérez de la Ossa D, Mura PA, Gil-Alegre ME. Bragagni M, et al. Int J Pharm. 2013 Jan 30;441(1-2):468-75. doi: 10.1016/j.ijpharm.2012.11.007. Epub 2012 Nov 16. Int J Pharm. 2013. PMID: 23164705

6

Development of liposomal and microemulsion formulations for transdermal delivery of clonazepam: effect of randomly methylated β-cyclodextrin.

Mura P, Bragagni M, Mennini N, Cirri M, Maestrelli F. Mura P, et al. Among authors: bragagni m. Int J Pharm. 2014 Nov 20;475(1-2):306-14. doi: 10.1016/j.ijpharm.2014.08.066. Epub 2014 Sep 4. Int J Pharm. 2014. PMID: 25194352

7

Improving the therapeutic efficacy of prilocaine by PLGA microparticles: Preparation, characterization and in vivo evaluation.

Bragagni M, Gil-Alegre ME, Mura P, Cirri M, Ghelardini C, Di Cesare Mannelli L. Bragagni M, et al. Int J Pharm. 2018 Aug 25;547(1-2):24-30. doi: 10.1016/j.ijpharm.2018.05.054. Epub 2018 May 23. Int J Pharm. 2018. PMID: 29800738

8

Development of a new delivery system consisting in "drug--in cyclodextrin--in nanostructured lipid carriers" for ketoprofen topical delivery.

Cirri M, Bragagni M, Mennini N, Mura P. Cirri M, et al. Among authors: bragagni m. Eur J Pharm Biopharm. 2012 Jan;80(1):46-53. doi: 10.1016/j.ejpb.2011.07.015. Epub 2011 Aug 4. Eur J Pharm Biopharm. 2012. PMID: 21839833

9

Development and characterization of functionalized niosomes for brain targeting of dynorphin-B.

Bragagni M, Mennini N, Furlanetto S, Orlandini S, Ghelardini C, Mura P. Bragagni M, et al. Eur J Pharm Biopharm. 2014 May;87(1):73-9. doi: 10.1016/j.ejpb.2014.01.006. Epub 2014 Jan 23. Eur J Pharm Biopharm. 2014. PMID: 24462793

10

Liposomal formulations of prilocaine: effect of complexation with hydroxypropyl-ß-cyclodextrin on drug anesthetic efficacy.

Bragagni M, Maestrelli F, Mennini N, Ghelardini C, Mura P. Bragagni M, et al. J Liposome Res. 2010 Dec;20(4):315-22. doi: 10.3109/08982100903544169. Epub 2010 Jan 28. J Liposome Res. 2010. PMID: 20109055

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters